Work

Carfilzomib-based strategies in transplant-eligible multiple myeloma: long-term follow-up of the phase 2 FORTE trial

Year: 2026
Type: article
Study design: Clinical Trial
Source: Blood
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: closed
OpenAlex ID: W7234489390
FWCI:
Cites:
Cited by:
Related to: 10